Premium
Paradoxical simultaneous regression and progression of lesions in a phase II study of everolimus in classic Kaposi sarcoma
Author(s) -
Mourah S.,
Porcher R.,
Battistella M.,
Kerob D.,
Guillot B.,
Jouary T.,
Agbalika F.,
Morinet F.,
Furlan V.,
Teisserenc H.M.,
Dupin N.,
Lebbé C.
Publication year - 2015
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.13897
Subject(s) - everolimus , medicine , sarcoma , response evaluation criteria in solid tumors , oncology , transplantation , pi3k/akt/mtor pathway , etoposide , pharmacodynamics , sirolimus , mucositis , clinical trial , phases of clinical research , chemotherapy , pathology , pharmacokinetics , apoptosis , biochemistry , chemistry